Benzene Presence Prompts Recall of Americaine 20% Benzocaine Topical Anesthetic Spray

Insight Pharmaceuticals has initiated a recall for one lot of its Americaine 20% Benzocaine Topical Anesthetic Spray due to the presence of benzene. The recall is valid across the United States and comes after third-party testing showed a low level of benzene in the product. The benzene was found to come from the propellant used to spray the product out of the can. The affected lot codes are 1A16420 with a National Drug Code of 63736-378-02 and an expiration date of 01/25, and the product was distributed nationwide through retailers and online. Benzene is a carcinogen that can enter the body through inhalation, orally, or through the skin, and can lead to life-threatening cancers and blood disorders. Insight is offering reimbursement for consumers who have purchased the spray and can be contacted through email, website, or phone. There have been no reports of illness related to the recall so far. If you have been affected by the recall, you can contact Insight Pharmaceuticals for further information.